Previous studies of other cancers [37,38] and our study [36] have indicated that mTOR targeting may induce cytostatic effects rather than the effective eradication of tumor cells, suggesting the potential advantage of combining mTOR targeting with cytotoxic agents. Here, MTOR is linked to neoplasm.